# Novalung merged into Xenios AG

Novalung GmbH was absorbed into Xenios AG on August 30, 2019, streamlining processes and aligning more closely with parent company Fresenius Medical Care. The merger was notarized and entered in the commercial register in mid-August.

- Type: Acquisition
- Announced: 2019-09-02
- Where: Germany
- Status: completed
- Products: respiratory failure solutions, lung support products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Fresenius Medical Care](https://endata.com/companies/2053.md) (partner)
- [Xenios AG](https://endata.com/companies/41776.md) (acquirer)
- [Novalung GmbH](https://endata.com/companies/41777.md) (target)

## Sources

- [xenios-ag.com](https://www.xenios-ag.com/2019/09/02/merger-novalung-becomes-fully-integrated-within-xenios/), 2019-09-02: "Novalung GmbH, which specialises in solutions for respiratory failure, was absorbed into Xenios AG on 30 August 2019."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.